Contraceptive efficacy and side effects of Implanon. 2007

K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
Selcuk University, Medical Faculty of Meram, Department of Obstetrics and Gynaecology, Konya, Turkey. kazimgezginc@hotmail.com

OBJECTIVE To determine the efficacy and side effects of Implanon used for long-term contraception. METHODS Prospective study of 80 patients who used Implanon for long-term contraception between January 2004 and January 2006. Side effects, efficacy and removals were recorded. RESULTS Amenorrhoea, infrequent bleeding and frequent bleeding were reported by 33 (41.25%), 19 (23.75%) and 14 patients (17.5%), respectively. Non-menstrual side effects comprised breast tenderness in 15 patients (18.75%), acne in eight (10%), headache and dizziness in three (3.75%); depressive mood disorders, pelvic pain and loss of libido were mentioned each by two of the women (2.5%). During the study period, Implanon was removed from 20 participants. No problem was encountered during its placement or removal. CONCLUSIONS Patients considering use of Implanon must be carefully selected and informed about its expected side effects before placement.

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003271 Contraceptive Agents, Female Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. Contraceptives, Female,Agents, Female Contraceptive,Female Contraceptive Agents,Female Contraceptives
D004343 Drug Implants Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug. Drug Implant,Drug Pellet,Pellets, Drug,Drug Pellets,Implant, Drug,Implants, Drug,Pellet, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014421 Turkey Country in Southeastern Europe and Southwestern Asia bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria. The capital is Ankara. Turkiye
D017135 Desogestrel A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents (ORAL CONTRACEPTIVES, COMBINED). 18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17alpha)-,13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol,Cerazette,Marvelon,Org-2969,13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol,Org 2969,Org2969,alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17
D064420 Drug-Related Side Effects and Adverse Reactions Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. Drug-Related Side Effects and Adverse Reaction,Adverse Drug Event,Adverse Drug Reaction,Drug Side Effects,Drug Toxicity,Side Effects of Drugs,Toxicity, Drug,Adverse Drug Events,Adverse Drug Reactions,Drug Event, Adverse,Drug Events, Adverse,Drug Reaction, Adverse,Drug Reactions, Adverse,Drug Related Side Effects and Adverse Reaction,Drug Related Side Effects and Adverse Reactions,Drug Side Effect,Drug Toxicities,Effects, Drug Side,Reactions, Adverse Drug,Side Effect, Drug,Side Effects, Drug,Toxicities, Drug

Related Publications

K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
January 1978, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
June 2001, Current opinion in obstetrics & gynecology,
K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
April 1999, Human reproduction (Oxford, England),
K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
March 2001, Contraception,
K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
April 2017, The journal of family planning and reproductive health care,
K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
May 2005, Contraception,
K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
June 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception,
K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
December 2007, Nursing for women's health,
K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
January 2008, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN,
K Gezginc, and O Balci, and R Karatayli, and M C Colakoglu
December 2010, Journal of pediatric and adolescent gynecology,
Copied contents to your clipboard!